X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (8) 8
cancer (7) 7
female (7) 7
adult (6) 6
aged (6) 6
male (6) 6
middle aged (6) 6
mutation (6) 6
oncology (6) 6
analysis (5) 5
lung neoplasms - pathology (5) 5
aged, 80 and over (4) 4
chemotherapy (4) 4
lung adenocarcinoma (4) 4
metastases (4) 4
metastasis (4) 4
tumors (4) 4
adenocarcinoma (3) 3
cancer therapies (3) 3
cell line, tumor (3) 3
chromosomes (3) 3
cisplatin (3) 3
genomes (3) 3
lung cancer (3) 3
lung neoplasms - blood (3) 3
neoplasm metastasis (3) 3
patients (3) 3
phylogeny (3) 3
survival (3) 3
adenocarcinoma - pathology (2) 2
adenocarcinoma of lung (2) 2
adenocarcinoma of lung - pathology (2) 2
alleles (2) 2
animals (2) 2
b7-h1 antigen - metabolism (2) 2
biomarkers, tumor (2) 2
biomarkers, tumor - metabolism (2) 2
care and treatment (2) 2
chickens (2) 2
cisplatin - administration & dosage (2) 2
cisplatin - adverse effects (2) 2
clonal evolution (2) 2
death-ligand 1 (2) 2
deoxyribonucleic acid--dna (2) 2
disease progression (2) 2
dna (2) 2
dna repair (2) 2
dt40 (2) 2
evolution (2) 2
evolution, molecular (2) 2
gemcitabine (2) 2
genetic aspects (2) 2
genetic heterogeneity (2) 2
genetic variation (2) 2
genome (2) 2
immune checkpoint (2) 2
immunohistochemistry (2) 2
longitudinal studies (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - immunology (2) 2
microenvironment (2) 2
models, statistical (2) 2
mutagenesis (2) 2
mutations (2) 2
paclitaxel (2) 2
pd-1 (2) 2
pd-l1 (2) 2
phenotype (2) 2
prognosis (2) 2
programmed cell death 1 receptor - metabolism (2) 2
prospective studies (2) 2
renal function (2) 2
retrospective studies (2) 2
sequence (2) 2
sequence analysis, dna (2) 2
whole genome sequencing (2) 2
5-fluorouracil (1) 1
active surveillance (1) 1
adenocarcinoma - diagnosis (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - immunology (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma of lung - blood (1) 1
adenocarcinoma of lung - drug therapy (1) 1
adenocarcinoma of lung - genetics (1) 1
adenocarcinoma of lung - immunology (1) 1
adenocarcinoma of lung - surgery (1) 1
adp (1) 1
afatinib (1) 1
agents (1) 1
algorithms (1) 1
ancestry (1) 1
anti-pd-l1 antibody (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic agents - toxicity (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Genome Biology, ISSN 1474-7596, 05/2016, Volume 17, Issue 1, pp. 1 - 16
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 3, pp. 694 - 704
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 7/2018, Volume 144, Issue 7, pp. 1219 - 1226
While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been... 
Immunohistochemistry | Chemotherapy | Medicine & Public Health | Hematology | Lung cancer | PD-L1 | Oncology | Cancer Research | Internal Medicine | PD-1 | CELLS | MICROENVIRONMENT | BIOMARKER | ONCOLOGY | AGENTS | UP-REGULATION | BIOPSIES | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Leukocytes, Mononuclear - immunology | Programmed Cell Death 1 Receptor - biosynthesis | Adult | Female | Neoadjuvant Therapy | Paclitaxel - administration & dosage | Bronchoscopy | Carcinoma, Non-Small-Cell Lung - pathology | Adenocarcinoma - immunology | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | B7-H1 Antigen - immunology | Carcinoma, Squamous Cell - immunology | Carcinoma, Non-Small-Cell Lung - immunology | Leukocytes, Mononuclear - pathology | Lung Neoplasms - immunology | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | B7-H1 Antigen - biosynthesis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Programmed Cell Death 1 Receptor - immunology | Deoxycytidine - analogs & derivatives | Care and treatment | Cancer patients | Analysis | Cancer
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 11624 - 9
textabstractCommunity level genetic information can be essential to direct health measures and study demographic tendencies but is subject to considerable... 
POPULATION | ORIGIN | MTDNA | DNA | MULTIDISCIPLINARY SCIENCES | SEQUENCE | RISK | DIVERSITY | MUTATIONS | MEDICINE | ANCESTRY | Sewage disposal | Mitochondrial DNA | Sewage | Population genetics | Migration | Genotypes
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2019, Volume 145, Issue 3, pp. 694 - 704
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 01/2018, Volume 122, Issue 1, pp. 126 - 132
Renal function impairment in lung cancer patients with bone metastases was investigated, as this can limit the application of bisphosphonates representing the... 
ZOLEDRONIC ACID | BREAST-CANCER | SURVIVAL | IMPACT | DENOSUMAB | IMPROVEMENT | PHARMACOLOGY & PHARMACY | COMPLICATIONS | TOXICOLOGY | PREVALENCE | COMORBIDITY | Diabetes Mellitus - blood | Humans | Middle Aged | Bone Neoplasms - secondary | Bone Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Lung Neoplasms - physiopathology | Renal Insufficiency - epidemiology | Urea - blood | Pulmonary Disease, Chronic Obstructive - epidemiology | Kidney Function Tests | Hypertension - blood | Renal Insufficiency - physiopathology | Pulmonary Disease, Chronic Obstructive - blood | Aged, 80 and over | Diphosphonates - therapeutic use | Adult | Female | Retrospective Studies | Bone Neoplasms - drug therapy | Hypertension - epidemiology | Bone Neoplasms - blood | Renal Insufficiency - blood | Kidney - physiopathology | Kidney - drug effects | Comorbidity | Bone Density Conservation Agents - therapeutic use | Hypertension - physiopathology | Bone Density Conservation Agents - pharmacology | Lung Neoplasms - epidemiology | Diabetes Mellitus - physiopathology | Diabetes Mellitus - epidemiology | Creatinine - blood | Aged | Lung Neoplasms - blood | Diphosphonates - pharmacology | Diabetics | Care and treatment | Analysis | Hypertension | Creatinine | Renal function | Statistical analysis | Lung cancer | Diabetes mellitus | Impairment | Data processing | Hazards | Metastasis | Multivariate analysis | Patients | Bisphosphonates | Metastases | Urea | Bone cancer | Statistical models | Chronic obstructive pulmonary disease | Diabetes | Bone | Median (statistics) | Cancer | Kidney transplantation | Index Medicus
Journal Article
Cell, ISSN 0092-8674, 04/2018, Volume 173, Issue 3, pp. 595 - 610.e11
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 01/2017, Volume 12, Issue 1, pp. S671 - S672
Journal Article
Journal Article
Clinical Lung Cancer, ISSN 1525-7304, 09/2019, Volume 20, Issue 5, pp. 363 - 369.e2
Approximately 50% of brain metastases originate from non–small-cell lung cancer. The median survival of patients with brain metastases is 1 month without... 
Immune environment | Immune checkpoint | Programmed death ligand 1 | Lung adenocarcinoma | ASSAY | DEATH-LIGAND 1 | TUMOR | OPEN-LABEL | PHASE-2 | PULMONARY SQUAMOUS-CELL | PEMBROLIZUMAB | ONCOLOGY | IMMUNOTHERAPY | NIVOLUMAB | IMMUNOHISTOCHEMISTRY
Journal Article
Basic & clinical pharmacology & toxicology, ISSN 1742-7835, 08/2017
Renal function impairment in lung cancer patients with bone metastases was investigated, as this can limit the application of bisphosphonates representing the... 
Journal Article